CHIMERIC THERAPEUTICS LIMITED IPO Analysis, page-103

A couple of things worth mentioning:

1) if CHM's technology is a sure thing, PH wouldn't have listed the company but rather kept it to himself like what he did with IMU's Vaxinia. Listing CHM is about balancing PH's risks and obviously he didn't have 100% or even 80% conviction that this thing will work let alone reach market.

2) None of the products to which PH has been associated with has ever become a product and released to the market. All are in clinical trials...still. (source: recent Eureka Report interview where AK asked PH this direct question).

The market cap and share price of CHM is simply flying blind at the moment until the market receive update/result from phase 1 clinical trial.